Skyrizi 00074-1070-01
Generic: Risankizumab-Rzaa
- Manufacturer
- Abbvie Inc.
- Dosage Form
- Kit
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 16, 2022
- Listing Expires
- December 31, 2027
- Application
- BLA761105
Need to source Skyrizi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Drug Class
Interleukin-23 Antagonist [EPC]
Selected Package
00074-1070-01Selected1 KIT in 1 CARTON (0074-1070-01) * 2.4 mL in 1 CARTRIDGE (0074-1069-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-01)
Other packages for this product(1)
1 KIT in 1 CARTON (0074-1070-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-01)